SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    U.S. Census Bureau. Census 2000 Summary File 1. Available from http://www.census.gov/
  • 2
    Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer incidence in five continents. IARC Scientific Publications No. 155, Volume VIII. Lyon, France: IARC, 2002.
  • 3
    Mack TM, Floderus B. Malignant melanoma risk by nativity, place of residence at diagnosis, and age at migration. Cancer Causes Control. 1991; 2: 401411.
  • 4
    Cress RD, Holly EA. Incidence of cutaneous melanoma among non-Hispanic whites, Hispanics, Asians, and blacks: an analysis of California cancer registry data, 1988–93. Cancer Causes Control. 1997; 8: 246252.
  • 5
    Cockburn M, Deapen D. Cancer incidence and mortality in California: trend by race/ethnicity 1988–2001. Sacramento, CA: Department of Health Services, 2004.
  • 6
    Percy C, Fritz A, Jack A, et al. International Classification of Diseases for Oncology (ICD-O), 3rd ed. Geneva: World Health Organization, 2000.
  • 7
    Balch CM, Soong SJ, Gershenwald JE, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer Melanoma Staging System. J Clin Oncol. 2001; 19: 36223634.
  • 8
    World Health Organization. International Classification of Diseases, Ninth Revision. Geneva: World Health Organization, 1977.
  • 9
    World Health Organization. International Statistical Classification of Diseases and Related Health Problems, Tenth Revision. Geneva: World Health Organization, 1992.
  • 10
    Stewart S, Glaser S, Horn-Ross P, West D. SEER study of methods to classify Hispanic cancer patients (final report: contract N01-CN-05224). Union City, CA: Northern California Cancer Center, 1993.
  • 11
    Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for JoinPoint regression with applications to cancer rates. Stat Med. 2000; 19: 335351.
  • 12
    Levi F, Randimbison L, La Vecchia C, Te VC, Franceschi S. Prognostic factors for cutaneous malignant melanoma in Vaud, Switzerland. Int J Cancer. 1998; 78: 315319.
  • 13
    MacKie RM, Hole D, Hunter JA, et al. Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979–94. The Scottish Melanoma Group. Br Med J. 1997; 315: 11171121.
  • 14
    MacKie RM, Hole DJ. Incidence and thickness of primary tumours and survival of patients with cutaneous malignant melanoma in relation to socioeconomic status. Br Med J. 1996; 312: 11251128.
  • 15
    Hall HI, Jones SE, Saraiya M. Prevalence and correlates of sunscreen use among US high school students. J School Health 2001; 71: 453457.
  • 16
    Friedman LC, Bruce S, Weinberg AD, Cooper HP, Yen AH, Hill M. Early detection of skin cancer: racial/ethnic differences in behaviors and attitudes. J Cancer Educ. 1994; 9: 105110.
  • 17
    Pipitone M, Robinson JK, Camara C, Chittineni B, Fisher SG. Skin cancer awareness in suburban employees: a Hispanic perspective. J Am Acad Dermatol. 2002; 47: 118123.
  • 18
    Saraiya M, Hall HI, Uhler RJ. Sunburn prevalence among adults in the United States, 1999. Am J Prevent Med. 2002; 23: 9197.